Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2012 |
| Author/s |
author: Natasha J. Caplen |
| Publication date | July 19, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |